Trevi Therapeutics
TRVI
#6339
Rank
C$0.86 B
Marketcap
$8.96
Share price
1.89%
Change (1 day)
158.38%
Change (1 year)

EPS for Trevi Therapeutics (TRVI)

EPS in 2023 (TTM): -$0.42

According to Trevi Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.43. In 2022 the company made an earnings per share (EPS) of -$0.78 an increase over its 2021 EPS that were of -$2.08.

EPS history for Trevi Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.42-45.94%
2022-$0.78-62.67%
2021-$2.08-17.29%
2020-$2.5118.17%
2019-$2.13-46.21%
2018-$3.95